Regenerative medicine: Targeted genome editing in vivo

Lixia Wang; Jun Wu; Weiwei Fang; Guang Hui Liu; Juan Carlos Izpisua Belmonte

doi:10.1038/cr.2015.11

Regenerative medicine: Targeted genome editing in vivo

Lixia Wang, Jun Wu, Weiwei Fang, Guang Hui Liu^*, Juan Carlos Izpisua Belmonte

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

Original language	English (US)
Pages (from-to)	271-272
Number of pages	2
Journal	Cell research
Volume	25
Issue number	3
DOIs	https://doi.org/10.1038/cr.2015.11
State	Published - Mar 5 2015
Externally published	Yes

ASJC Scopus subject areas

Molecular Biology
Cell Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/cr.2015.11

Cite this

@article{fa005e09fb16412f81d86a3602c88ebc,

title = "Regenerative medicine: Targeted genome editing in vivo",

abstract = "The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.",

author = "Lixia Wang and Jun Wu and Weiwei Fang and Liu, {Guang Hui} and Belmonte, {Juan Carlos Izpisua}",

year = "2015",

month = mar,

day = "5",

doi = "10.1038/cr.2015.11",

language = "English (US)",

volume = "25",

pages = "271--272",

journal = "Cell research",

issn = "1001-0602",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Regenerative medicine

T2 - Targeted genome editing in vivo

AU - Wang, Lixia

AU - Wu, Jun

AU - Fang, Weiwei

AU - Liu, Guang Hui

AU - Belmonte, Juan Carlos Izpisua

PY - 2015/3/5

Y1 - 2015/3/5

N2 - The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

AB - The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

UR - http://www.scopus.com/inward/record.url?scp=84924510585&partnerID=8YFLogxK

U2 - 10.1038/cr.2015.11

DO - 10.1038/cr.2015.11

M3 - Article

C2 - 25633595

AN - SCOPUS:84924510585

SN - 1001-0602

VL - 25

SP - 271

EP - 272

JO - Cell research

JF - Cell research

IS - 3

ER -

Regenerative medicine: Targeted genome editing in vivo

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this